Investigation of Copy Number Variation in South African Patients With Congenital Heart Defects

Nicole A Saacks1, James Eales2, Timothy F Spracklen1,3

  • 1Division of Pediatric Cardiology, Department of Pediatrics and Child Health (N.A.S., T.F.S., T.A., J.L., G.C., R.D.D., L.S., A.J., L.J.Z.).

Insights

This study identified copy number variants (CNVs) in South African children with congenital heart disease (CHD), revealing genetic factors similar to European populations. Novel candidate genes for CHD were also discovered in this diverse cohort.

Area of Science:

  • Genetics
  • Pediatrics
  • Genomics

Background:

  • Congenital heart disease (CHD) is a major global cause of childhood illness and death.
  • Genetic factors, including copy number variants (CNVs), are implicated in CHD risk, particularly in European populations.
  • The role of rare CNVs in African CHD populations remains largely unexplored.

Purpose of the Study:

  • To identify pathogenic and likely pathogenic CNVs in South African patients diagnosed with CHD.
  • To investigate the genetic underpinnings of CHD in an African pediatric cohort.

Main Methods:

  • Genotyping of 90 nonsyndromic CHD patients using the Affymetrix CytoScan HD platform.
  • Identification of large, rare CNVs in known CHD-associated and candidate genes.

Main Results:

  • Eight CNVs were found in known CHD-associated genes (e.g., GATA4, TBX1) in six patients.
  • CNVs in five candidate genes (e.g., DGCR8, JARID2) were identified in five patients.
  • A 6.7% overall discovery yield was achieved, with 5.6% of patients harboring pathogenic or likely pathogenic CNVs.

Conclusions:

  • Chromosomal microarray is effective for identifying CNVs in African CHD patients.
  • Genetic findings in this cohort are comparable to those in European CHD studies.
  • Novel potential CHD genes were identified, highlighting the importance of studying diverse populations.
Abstract